Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Oseltamivir in neonates, infants and young children: a focus on clinical pharmacology.

Karadag-Oncel E, Ceyhan M.

Infect Disord Drug Targets. 2013 Feb;13(1):15-24. Review.

PMID:
23675923
2.

Oseltamivir pharmacology in young children: a commentary.

Kamal MA.

Infect Disord Drug Targets. 2013 Feb;13(1):2-5.

PMID:
23675921
3.

Pharmacokinetics and pharmacodynamics of oseltamivir in neonates, infants and children.

Standing JF, Tsolia M, Lutsar I.

Infect Disord Drug Targets. 2013 Feb;13(1):6-14. Review.

PMID:
23675922
4.

Towards a personalised approach to managing influenza infections in infants and children - food for thought and a note on oseltamivir.

Rath B, Tief F, Karsch K, Muehlhans S, Obermeier P, Adamou E, Chen X, Seeber L, Peiser C, Hoppe C, von Kleist M, Conrad T, Schweiger B.

Infect Disord Drug Targets. 2013 Feb;13(1):25-33.

PMID:
23675924
5.

Neuraminidase inhibitors for preventing and treating influenza in children.

Wang K, Shun-Shin M, Gill P, Perera R, Harnden A.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD002744. doi: 10.1002/14651858.CD002744.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD002744.

PMID:
22258949
6.

Antiviral drugs for influenza.

[No authors listed]

Med Lett Drugs Ther. 2008 Dec 15-29;50(1301-1302):98-9, 104; quiz p following 104. No abstract available.

PMID:
19078865
7.

Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic.

Dixit R, Khandaker G, Ilgoutz S, Rashid H, Booy R.

Infect Disord Drug Targets. 2013 Feb;13(1):34-45. Review.

PMID:
23675925
8.

Oseltamivir use in adolescents and adults: clinical and economic considerations.

Yin JK, Heron L, Salkeld G, Rashid H, Booy R.

Infect Disord Drug Targets. 2013 Feb;13(1):53-8. Review.

PMID:
23675927
9.

Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).

Wang K, Shun-Shin M, Gill P, Perera R, Harnden A.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD002744. doi: 10.1002/14651858.CD002744.pub4. Review.

PMID:
22513907
10.

Oseltamivir in the management of influenza.

Oxford J.

Expert Opin Pharmacother. 2005 Nov;6(14):2493-500. Review.

PMID:
16259580
11.

Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection.

Sugaya N, Ohashi Y.

Antimicrob Agents Chemother. 2010 Jun;54(6):2575-82. doi: 10.1128/AAC.01755-09. Epub 2010 Apr 5.

12.

[Controversies about neuraminidase inhibitor. Is the influenza drug less effective than assumed?].

Haas W.

MMW Fortschr Med. 2010 Jan 21;152(3):7. German. No abstract available.

PMID:
20333956
13.

[Role of neuraminidase inhibitors for the treatment of influenza A virus infections].

Ferraris O, Escuret V, Bouscambert-Duchamp M, Lina B, Morfin F.

Pathol Biol (Paris). 2010 Apr;58(2):e69-78. doi: 10.1016/j.patbio.2010.01.011. Epub 2010 Mar 19. Review. French.

PMID:
20303677
14.

Oseltamivir for control of influenza at mass gatherings.

Tashani M, Rashid H, Ridda I, Heron L, Memish ZA, Haworth E, Booy R.

Infect Disord Drug Targets. 2013 Feb;13(1):46-52. Review.

PMID:
23675926
15.

Optimizing antiviral therapy for influenza: understanding the evidence.

Ison MG.

Expert Rev Anti Infect Ther. 2015 Apr;13(4):417-25. doi: 10.1586/14787210.2015.1018183. Epub 2015 Feb 19. Review.

PMID:
25695406
16.

Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.

Ikematsu H, Kawai N.

Expert Rev Anti Infect Ther. 2011 Oct;9(10):851-7. doi: 10.1586/eri.11.112. Review.

PMID:
21973296
17.

Safety and pharmacokinetics of oseltamivir for prophylaxis of neonates exposed to influenza H1N1.

Maltezou HC, Drakoulis N, Siahanidou T, Karalis V, Zervaki E, Dotsikas Y, Loukas YL, Theodoridou M.

Pediatr Infect Dis J. 2012 May;31(5):527-9. doi: 10.1097/INF.0b013e3182472f28.

PMID:
22209917
18.

Oseltamivir for the treatment of H1N1 influenza during pregnancy.

Beigi RH, Pillai VC, Venkataramanan R, Caritis SN.

Clin Pharmacol Ther. 2015 Oct;98(4):403-5. doi: 10.1002/cpt.179. Epub 2015 Jul 22. Review.

PMID:
26108913
19.

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.

Jefferson T, Jones MA, Doshi P, Del Mar CB, Heneghan CJ, Hama R, Thompson MJ.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008965. doi: 10.1002/14651858.CD008965.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;4:CD008965.

PMID:
22258996
20.

Neuraminidase inhibitors for preventing and treating influenza in children.

Matheson NJ, Symmonds-Abrahams M, Sheikh A, Shepperd S, Harnden A.

Cochrane Database Syst Rev. 2003;(3):CD002744. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD002744.

PMID:
12917931

Supplemental Content

Support Center